Communicable Disease Management Protocols

Introduction:  Purpose of the Manual

The prevention, management and control of communicable diseases requires the active participation and cooperation of all health-care professionals and practitioners.

While this manual is intended to act as a guide to the management and control of communicable diseases within the Province of Manitoba, professional judgment will still be required by those charged with providing health care services.

Protocols for specific communicable diseases contain epidemiologic information with reference to provincial and national trends. Detailed information related to laboratory testing, treatment and public health investigation is included in the protocols and reflects best practices at the time of release. As advances in scientific knowledge and health care practices become available, our collective response to well established as well as newly identified and evolving pathogens must be routinely reviewed and updated. Although the Manual will be updated periodically, practitioners must take responsibility to ensure that they have the most recent knowledge relating to the case they are dealing with and, for that reason, a list of resources has been included below.

The most current versions of the following publications:

• Canadian Immunization Guide – Public Health Agency of Canada
• Control of Communicable Diseases Manual – American Public Health Association
• Principles and Practices of Infectious Diseases – Elsevier
• Redbook: Report of the Committee on Infectious Diseases - American Academy of Pediatrics

The following organizations:

• Infectious Diseases Society of America (Practice Guidelines)
• Public Health Agency of Canada
• UpToDate
• US Centers for Disease Control and Prevention
• US National Institutes of Health
• World Health Organization

Most recent additions:

	Yersiniosis (February 2012) NEW
	Campylobacter Infection (February 2012) NEW
	Rabies:  Protocol for Management of Human Rabies and Management of Animal Exposures to Prevent Human Rabies (January 2012) NEW
	Shigellosis (November 2011) NEW
	Salmonellosis (Nontyphoidal) (November 2011) NEW
	Invasive Meningococcal Disease (Neisseria meningitidis) (June 2011) NEW
	Listeriosis (June 2011) NEW
	Manitoba Immunization Schedules - Reference Guide for Public Health Professionals (May 2011) NEW
	Measles/Mumps/Rubella (MMR) (April 2011) NEW
	Varicella (Chickenpox) Vaccine (April 2011) NEW
	Invasive Pneumococcal Disease (Streptococcus pneumoniae) (Pneumococcus) (January 2011) NEW
	Immunizing Agents and Biologics Order Form (April 2011) REVISED

---

Table of Contents

• Communicable Disease Surveillance
• Epidemiological Investigation of Outbreaks
• Control of Enteric Infections
• Reportable Diseases and Conditions by Health Professionals (HP) and Labs (L)  (April 2009)
• The Public Health Act Reporting Powers and Requirements  (May 2008)

Protocols:

Click on any of the underlined letters in the yellow bar to jump to a particular topic, or hit CTRL + F to search for a keyword.

Amebiasis (November 2001)

Anaphylactic Shock
         See:

Protocol for Management of Suspected Anaphylactic Shock (November 2007)

Anthrax (November 2001)

Antibiotic Resistant Organisms
         See:

	Manitoba Guidelines for the Prevention and Control of Antibiotic Resistant Organisms (AROs) (January 2007)
	Clostridium difficile-Associated Diseases (CDAD) (September 2006)

Blastomycosis (September 2007)
         See also:

	Blastomycosis (September 2007)
	La blastomycose (Septembre 2007)

Botulism (November 2001)

Brucellosis (November 2001)

Campylobacter Infection (February 2012)

Cervicitis (November 2001)

Chancroid (November 2001)

Children with Sexually Transmitted Diseases (STDs) (November 2001)

Chlamydia trachomatis (D through K Serovars) Infection (April 2008)
         See also:

	Chlamydia - Public Health Agency of Canada (February 2008)
	La chlamydia - Agence de la santé publique du Canada (février 2008)

Cholera (November 2001)

Clostridium difficile-Associated Diseases (CDAD) (September 2006)
         See also:

Clostridium difficile-Associated Diseases (CDAD) Infection Control Guidelines (September 2006)

Congenital/Neonatal H. Simplex Infection (November 2001)

Creutzfeldt-Jakob Disease (CJD) (November 2001)

Cryptosporidiosis (November 2001)
         See also:

	Cryptosporidium Infection (January 2006)
	Infection au Cryptosporidium (janvier 2006)

Cytomegalovirus Infection (November 2001)

Diphtheria (November 2001)
         See also:

	Tetanus, Diphtheria, and acellular Pertussis (Tdap) Vaccine (October 2010)
	Vaccin dcaT (diphtérie, coqueluche acellulaire et tétanos) (octobre 2010)

Enteric Illness Protocol (March 2008)
         See also:

	Gastroenteritis (Gastro) (July 2008)
	La gastroentérite (gastro) (juillet 2008)

Genital Herpes (November 2001)

Giardiasis (November 2001)
         See also:

	Giardia Infection (June 2001)
	Infection à la Giardia (juin 2001)

Gonorrhea (April 2008)
         See also:

	Gonorrhea - Public Health Agency of Canada (February 2008)
	La gonorrhée - Agence de la santé publique du Canada (février 2008)

Haemophilus influenzae Disease (October 2007)
         See also:

	Haemophilus Influenzae Type b (Hib) Vaccine REVISED October 2010
	Vaccin contre l’infection à Haemophilus influenzae de type b (Hib) MISE À JOUR October 2010
	Diptheria, Pertussis, Tetanus, Polio and Haemophilus influenzae type b (DTaP-IPV-Hib) Vaccine (July 2010)
	Vaccin DCaT-VPI-Hib pour prevénir la diphtérie, la coqueluche, le tétanos, la polio et l’haemophilus influenzae de type b (juillet 2010)

Hantavirus Infection Pulmonary Syndrome (November 2001)
         See also:

	Hantavirus Infection (January 2006)
	Infection au hantavirus (janvier 2006)
	Hantavirus Infection Pulmonary Syndrome

Hepatitis A (November 2001)

Hepatitis B (November 2008)

Hepatitis B Newborn Prophylaxis Protocols (November 2008)
         See also:

	Hepatitis B Vaccine (July 2009)
	L'immunisation contre l'hépatite B (juillet 2009)
	Hepatitis B and Your Baby  (from Fact Sheets for the Public) (March 2003)
	L'hépatite B et votre bébé (from Fact Sheets for the Public) (mars 2003)

Integrated Post-Exposure Protocol for HIV, HBV and HCV: Guidelines for Managing Exposures to Blood and Body Fluids (March 2009)

	What You Should Know If You Have Come Into Contact With Blood Or Body Fluids (June 2009)
	Ce que vous devez savoir si vous êtes entré en contact avec du sang ou des liquides corporels  (Juin 2009)

Sexually Transmitted Infections and Bloodborne Pathogens

Hepatitis C (June 2009)
         See also:

Integrated Post-Exposure Protocol for HIV, HBV and HCV: Guidelines for Managing Exposures to Blood and Body Fluids (March 2009)

	What You Should Know If You Have Come Into Contact With Blood Or Body Fluids (June 2009)
	Ce que vous devez savoir si vous êtes entré en contact avec du sang ou des liquides corporels  (juin 2009)
	Hepatitis C - Public Health Agency of Canada (May 2008)
	Hépatite C - Agence de la santé publique du Canada (mai 2008)

Sexually Transmitted Infections and Bloodborne Pathogens

Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) (February 2010)
         See also:

Integrated Post-Exposure Protocol for HIV, HBV and HCV: Guidelines for Managing Exposures to Blood and Body Fluids (March 2009)

	What You Should Know If You Have Come Into Contact With Blood Or Body Fluids (June 2009)
	Ce que vous devez savoir si vous êtes entré en contact avec du sang ou des liquides corporels  (juin 2009)
	Medications to Reduce the Risk of HIV Infection (June 2009)
	Les médicaments pour réduire le risque d’infection par le VIH (juin 2009)
	Human Immunodeficiency Virus (HIV) - Public Health Agency of Canada(February 2008)
	virus de l’immunodéficience humaine - Agence de la santé publique du Canada (février 2008)

Sexually Transmitted Infections and Bloodborne Pathogens

Influenza NEW (October 2011)
         See also:

Seasonal Flu (The Flu) (July 2011)

Invasive Meningococcal Disease (Neisseria meningitidis) NEW
(June 2011)
         See also:

	What You Should Know About Ciprofloxacin (or Cipro) (June 1998)
	Ce qu’il faut savoir au sujet de la ciprofloxacine (ou cipro) (juin 1998)
	Meningococcal Conjugate C Vaccine (October 2008)
	Le vaccin antiméningococcique conjugué contre les méningococcies du groupe C (octobre 2008)
	Letter to Public Health staff providing an update on the rifampin / ciprofloxacin depot system (December 2005)
	Important Notes on Rifampin (Also known as Rifadin, Rimactane, Rifampicin, Rofact) (February 1995)
	Meningococcal Rifampin Dosage Table (For children more than one (1) month and adults)

Invasive Pneumococcal Disease (Streptococcus pneumoniae) (Pneumococcus) NEW
(January 2011)
         See also:

	Pneumococcal Polysaccharide Vaccine (Pneu-P-23) (July 2011)
	Le vaccin polysaccharidique antipneumococcique (Pneu-P-23) (juillet 2011)

Legionellosis (November 2001)

Leprosy (November 2001)

Listeriosis (June 2011) NEW

Lyme Disease (November 2001)

Lymphogranuloma Venereum (LGV) (May 2007)

See also:

	Lymphogranuloma Vernerum (LGV) - Public Health Agency of Canada(February 2008)
	lymphogranulome vénérien - Agence de la santé publique du Canada (février 2008)

Malaria (November 2001)

Manitoba Immunization Schedules - Reference Guide for Public Health Professionals (May 2011) NEW

Measles (Rubeola) (July 2010)
         See also:

	Measles/Mumps/Rubella (MMR) (April 2011) NEW
	Vaccin associé Rougeole-Oreillons-Rubéole (ROR) (juin 2005)

Methicillin and Vancomycin Resistant Staphylococcus aureus (MRSA/VRSA) Infection
         See:

Manitoba Guidelines for the Prevention and Control of Antibiotic Resistant Organisms (AROs) (January 2007)

Admission Screening Statement for MRSA and VRE for Acute Care Facilities and Surgical Centres January 2007

Molluscum Contagiosum (November 2001)

Mumps (July 2010)

Parvovirus B19 Infection (Fifth Disease) (November 2001)

Pediculosis (Head, Body or Crab Lice) (November 2001)
         See also:

	Head Lice Control Check List (February 2005)
	Liste de vérification en cas d’infestation de poux de tête (December 1998)
	Head Lice (February 2005)
	Poux de tête (septembre 1999)

Pertussis/Parapertussis (November 2007)
         See also:

	Diptheria, Tetanus, Pertussis, Polio and Haemophilus influenzae type b (DaPTP-Hib) Vaccine (July 2010)
	Vaccin DCaT-VIP-Hib pour prevénir la diphtérie, le tétanos, la coqueluche, la polio et l’haemophilus influenzae de type b (juillet 2010)
	DTap-IPV Vaccine to Prevent Diphtheria, Pertussis, Tetanus and Polio (July 2010)
	Le vaccin DCat-VPI pour prévenir la Diphtérie, la Coqueluche, le Tétanos et la Polio (juillet 2010)
	Tetanus, Diphtheria, and acellular Pertussis (Tdap) Vaccine (October 2010)
	Vaccin dcaT (diphtérie, coqueluche acellulaire et tétanos) (octobre 2010)

Plague (November 2001)
         See also:

• Recommended Guidelines for Suspected Plague Cases at Winnipeg International Airport (September 1997)

Poliovirus Infections (November 2001)
         See also:

	DTap-IPV Vaccine to Prevent Diphtheria, Pertussis, Tetanus, Polio (July 2010)
	Le vaccin DCat-VPI pour prévenir la Diphtérie, la Coqueluche, le Tétanos et la Polio (juillet 2010)
	Diptheria, Pertussis, Tetanus, Polio and Haemophilus influenzae type b (DaPTP-Hib) Vaccine (July 2010)
	Vaccin DCaTP-VIP-Hib pour prevénir la diphtérie, la coqueluche, le tétanos, la polio et l’haemophilus influenzae de type b (juillet 2010)

Psittacosis (November 2001)

Rabies:  Protocol for Management of Human Rabies and Management of Animal Exposures to Prevent Human Rabies (January 2012)
         See also:

	Collection and Shipping of Samples for Laboratory Testing for Rabies (April 1995) [refer to: Rabies:  Protocol for Management of Human Rabies and Management of Animal Exposures to Prevent Human Rabies]
	Rabies Fact Sheet (April 2006)

Respiratory Syncytial Virus Infection (RSV) (November 2001)

Rubella and Congenital Rubella Syndrome/Infection (November 2010)
         See also:

	Measles/Mumps/Rubella (MMR) (April 2011)
	Vaccin associé Rougeole-Oreillons-Rubéole (ROR) (juin 2005)
	Rubella Fact Sheet

Salmonellosis (Nontyphoidal) (November 2011) NEW

Scabies (November 2001)

Sexually Transmitted Infections Treatment Guidelines (April 2008)
         See also:

• STI Medication Order Form (April 2008)

Sexually Transmitted Enteric Infections (November 2001)

Shigellosis (November 2011) NEW

Staphylococcal Food Intoxication (November 2001)

Streptococcal Disease (Group A Invasive) (November 2007)
         See also:

	Information for Physicians on Invasive Group A Streptococcal Necrotizing Fasciitis, Necrotizing Myositis and Toxic Shock Syndrome (October 2000)
	Necrotizing Fasciitis (Flesh-eating Disease) (May 2001)
	Fasciite nécrosante (maladie dévoreuse de chair) (mai 2001)

Streptococcal (Group B) Disease of the Newborn (November 2001)

Syphilis (August 2007)
         See also:

	Syphilis - Public Health Agency of Canada (February 2008)
	La syphilis - Agence de la santé publique du Canada (février 2008)
	Sexually Transmitted Infections and Bloodborne Pathogens

Tetanus (November 2001)
         See also:

	Tetanus and Diphtheria (Td) Vaccine REVISED October 2010
	Vaccin contre le tétanos et la diphtérie (Td) MISE À JOUR October 2010
	Tetanus, Diphtheria, and acellular Pertussis (Tdap) Vaccine (October 2010)
	Vaccin dcaT (diphtérie, coqueluche acellulaire et tétanos) (octobre 2010)

Toxoplasmosis (November 2001)

Travel (February 2008)

Trichinosis (November 2001)

Tuberculosis (TB) (December 2009)
         See also:

	Tuberculosis (TB) (January 2006)
	Tuberculose (janvier 2006)

Tularemia
         See:

Information for Health Care Professionals (October 2004)

Typhoid and Paratyphoid Fever (November 2001)

Urethritis (November 2001)

Vancomycin Resistant Enterococci (VRE)
         See:

Manitoba Guidelines for the Prevention and Control of Antibiotic Resistant Organisms (AROs) (January 2007)

Vancomycin Resistant Staphylococcus aureus
         See:

Manitoba Guidelines for the Prevention and Control of Antibiotic Resistant Organisms (AROs) (January 2007)

Varicella/Herpes Zoster (Chickenpox/Shingles) (November 2001)
         See also:

Varicella (Chickenpox) Vaccine (April 2011) NEW

Verotoxigenic Escherichia coli (VTEC) Infection (May 2007)

Viral Meningitis/Encephalitis (November 2001)

West Nile virus Public Health Human Case Investigation Protocol (July 2006)

Yellow Fever (November 2001)

Yersiniosis (February 2012)

 

• Immunizing Agents and Biologics Order Form
  (Aug. 2011)
• Communicable Disease Control Investigation Form
• Hepatitis B Prophylaxis Record Sheet for Infants
  November 2008
• HIV/AIDS Case Report
• HIV Case Investigation Form for Nominal & Non-Nominal Positive Cases
  revised January 2008
• HIV Case Report Form for Anonymous Testing
  April 2008
• HIV Case Report Form for Rapid HIV Testing
  April 2008
• HIV Contact Notification Form
  December 2006
• HIV Post-Exposure Prophylaxis Drug Order Form
  (March 2009)
• Information Record:  HIV Post-Exposure Prophylaxis
  (March 2009)
• Instructions for STD Medication Administration Form
• Investigation Form for Hepatitis B and C Positive Cases
  (June 2009)
• Meningococcal Contact Form
  (Revised December 2005)
• Meningococcal Post Exposure Prophylaxis Invoicing Process
  (April 2012)
• Notification of Sexually Transmitted Disease
• Phone Report of Possible Rabies Exposure
• Outbreak Report
• Report of Adverse Events Following Immunization (AEFI) Form
• STI Medication Order Form
  (Revised April 2008)
• STI Medication Administration Form
  (Revised March 2009)
• West Nile virus Public Health Human Case Investigation Short Form 2008
• West Nile virus Public Health Human Case Investigation Long Form 2008